About
Dr. Sourabh Jain Ph.D (M.Pharm Pharmacognosy) is an Professor in Arihant School of Pharmacy & Bio-Research Institute, Gandhinagar, Gujrat INDIA with 13 years of academic and research experience. He is completed his Ph.D. from Shobhit university, Meerut U.P., India, M. Pharm from Smriti College of Pharmaceutical Education, Indore, M.P., India and B. Pharm from B.R.Nahata College of Pharmacy, Mandsaur. M.P., India. He has published more than 25 papers in national and international journals, 01 book published by Springer Nature, 01 project completed funded by MPCST, Bhopal (Co- Investigator) and 05 foreign visits for paper presentation with full travel grant. He is Member of various societies like EAACI Zurich Switzerland, MDS USA, EACR United Kingdom, GA Germany, ISPOR USA and ISP, India. His key area of research Pharmacological and screening of herbal drug, Quality control of Ayurvedic formulation and Targeted drug delivery of phytopharmaceuticals for the treatment of cancer, parkinsonism and Diabetes.
Employment
Employment history is unavailable.
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (52)
- Herbal Drug Licensing and Compliance Save
- Isolation Techniques of the Phytocompounds of Medicinal Plants Save
- Plant extracts of Aegle marmelos L. and Moringa oleifera Lam. for cumin wilt management: antioxidant activity, bioefficacy, and analytical insights Save
- Phytochemical analysis and synergistic memory enhancing effect of Bacopa monnieri with Piper nigrum Save
- Potential of natural polymeric materials in pharmaceutics Save
- Editorial: Novel approaches in the prevention of bacterial biofilm formation Save
- Exploring brucine alkaloid: A comprehensive review on pharmacology, therapeutic applications, toxicity, extraction and purification techniques Save
- Peptide and protein delivery through acacia, tragacanth, and ghatti gum Save
- Effect of Naringin Co-administration on Oral Bioavailability of Efavirenz in Rabbit Save
- COVID-19 Potential To Infect 4.44% Indian Population Save